Algeria vs Botswana: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Algeria
95.0%
in 2025
Botswana
95.0%
in 2025
Algeria rank
38th
Botswana rank
38th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Algeria
- Botswana
How they compare
Algeria currently reports 95.0% against 95.0% in Botswana, a difference of 0.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Botswana ahead.
Algeria ranks 38th and Botswana ranks 38th of 194 countries.
Botswana has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Algeria | Botswana | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 32.8% | 66.8% | 34.0% | Botswana |
| 2020s | 84.8% | 88.8% | 4.0% | Botswana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Algeria or Botswana?
- Algeria, at 95.0% against 95.0% in Botswana as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Algeria and Botswana?
- 0.0%, with Algeria ahead.
- How many years of comparable data are there for Algeria and Botswana?
- 18 years are reported by both, from 2008 to 2025.
- How do Algeria and Botswana rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Algeria ranks 38th and Botswana ranks 38th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.